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Summary
Endovascular repair (EVAR) of abdominal aortic aneu-
rysms (AAA) is an established alternative option to 
 conventional surgery for AAA, provided optimal ana-
tomical morphology of the aneurysm sac, neck and 
outflow exists. In most documented series of EVAR, 
type-II endoleak occurrence is a universal procedural 
drawback. This is referred to as the Achilles heel 
of EVAR. This morphological study, addressing pre-
dominantly non-aneurysmal aortic anatomy, reveals 
the dyssynchronous origins of the renal ostia, ectopia 
of the superior mesenteric artery and median sacral 
artery, variations in the length of the infrarenal abdom-
inal aorta, multiple mainstem renal arteries, and 
the presence of accessory renal arteries (in 13% of 
cadavers). Such potential vascular anomalies need
careful consideration pre-operatively prior to EVAR. 
In a prospective, clinical study of EVAR in 163 
patients over 60 months, using four different aortic stent 
devices, we demonstrated an intraprocedural type-II 
endoleak rate, before exclusion, of 3% (5/163). Most 
were related to patent lumbar arteries. An active policy 
of intraprocedural aneurysm pressure sac measurement 
and angiography was used to demonstrate type-I and 
type-II endoleaks, focusing on the applied anatomy of 
aortic side branches and variations. Selective intrapro-
cedural coil embolisation and thrombin injection into 
the sac was utilised to thrombose persisting and large 
lumbar arteries that predisposed to retroleaks. We 
recorded a low incidence of persisting type-II endoleaks 
using this proactive treatment strategy by addressing 
variant aortic morphology and patent lumbar arteries 
during EVAR. One aneurysm-related death (0.6%) was 
observed due to late rupture after EVAR, and a single 
intraprocedural death was related to unpredictable 
aneurysm rupture.
In conclusion, comprehensive anatomical knowledge 
of the abdominal aorta and its main collateral side 
branches, including variations, is a fundamental pre-
requisite if satisfactory and predictable results are to 
be achieved after EVAR, especially regarding preven-
tion, diagnosis and treatment of type-II endoleaks. 
Intraprocedural aneurysm sac pressure monitoring, coil 
embolisation and the use of injection of thrombin into the 
aneurysm sac of selected patients is useful in reducing the 
incidence of post-EVAR type-II persisting endoleaks.
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The object of definitive exclusion of abdominal aortic 
aneurysms (AAA), either by conventional aneurysmectomy 
or endovascular aortic aneurysm repair (EVAR), is to 
prevent or reduce rupture and predictable aneurysm-related 
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death.1-3 Important causes of death following rupture of an 
abdominal aortic aneurysm include exsanguinating haemor-
rhage and multiple organ failure.1 Sadly, death due to 
aneurysm rupture can be clinically missed, as shown in 
our cadaver study.
Until 10 years ago, all patients with large AAA, including 
selected octogenarians declared fit for surgery, underwent 
conventional aneurysmectomy and prosthetic engraftment. 
Evidence-based studies show that predictable rupture can 
be prevented by this treatment.1 In about 70% of surgical 
cases, it is feasible to exclude AAA by insertion of a short 
interposition Dacron or PTFE tubular graft. The Cleveland 
Clinic Foundation has confirmed, in a large series, that open 
repair of AAA in properly selected octogenarians is safe 
and durable.4 In almost all cases, this meant a single, 
definitive, cost-effective intervention. This group, over a 
nine-year period, reported an 8% 30-day mortality rate 
for 114 octogenarians who had had open surgical repair.4 
Other high-volume vascular units report low in-hospital 
mortality rates following conventional aneurysm surgery in 
octogenarians.5-8 Most series report freedom of aneurysm rup-
ture after aneurysmectomy in excess of 95%, therefore con-
firming the durability of conventional aneurysm surgery.4-7
In 1976, Parodi of Buenos Aires pioneered the concept 
of endoluminal aneurysm exclusion.9 EVAR today is a 
recognised alternative to conventional surgery in selected 
patients with AAA meeting inclusion criteria.10-13 About 75% 
of AAA referrals to high-volume vascular units, including 
high-risk patients and octogenarians, can be managed by 
elective EVAR, provided aneurysm morphology is favour-
able. Motivation for EVAR include reduced hospital stay, 
less postoperative pain, reduced transfusion requirements 
and rapid rehabilitation.10-13 Compared to conventional aneu-
rysmectomy, the Achilles heel of EVAR is the development 
and consequences of endotension, endoleaks, especially 
regarding a predisposition to late rupture, and aneurysm-
related death.14-26 Our group believes this is due to a disregard 
for the anatomy of the aorta and side branches, including 
variations. A second cost-ineffective drawback is the need 
for secondary interventions in about 20% of patients post-
EVAR.20,22,23 Single or multiple negative factors such as 
endoleaks, endotension, stent-migration and stent-fracture 
have bedevilled the application of early-generation stents. 
Development of new-generation endografts have steadily 
overcome these initial drawbacks.10
The purpose of this morphological study was to empha-
sise the importance of clinically relevant surgical anatomy 
of the abdominal aorta, aberrant vessels, side branches, vari-
ations, collateral circulation and juxta-renal region morphol-
ogy specific to EVAR and type-II endoleaks. Secondly, we 
report on the incidence and outcome of type-II endoleaks 
in a series of 163 patients undergoing prospective, elective 
EVAR and entered into the VASSA Registry during 2003.
Materials and methods
Critical aortic morphology relevant to EVAR
Cadaveric dissection of the abdominal aorta and collateral 
side branches, inferior to the superior mesenteric artery, 
was performed in a small cohort (31 human aortas) on 
predominantly non-aneurysmal aortas. One patient had an 
undiagnosed aortic aneurysm rupture that resulted in death. 
Standard and surgical anatomy literature was consulted 
before and during dissection.27-31 Special emphasis was 
placed on dissection of aberrant vessels, aortic anomalies, 
variations, renal arteries, ostia and take-off and all anatomi-
cal features that impact on EVAR. Patency and numbers of 
all side branches, including variations, were carefully noted, 
analysed and recorded. Circumferential measurements of the 
aorta were made using a vernier calliper at varying levels. 
Anomalies of the abdominal aorta impacted on inclusion 
and exclusion criteria with regard to EVAR. Special care 
was taken to study dorsal aortic surface distribution of 
atherosclerosis, plaques and patency of lumbar arteries and 
ectopic median sacral ostia.
Regarding the juxtarenal ostial area, circumferential 
measurements were carefully obtained using a graded 
vernier calliper. In the clinical situation, this data is needed 
to facilitate secure proximal stent fixation and the preven-
tion of type-I endoleaks. Readings were obtained from 
the superior and inferior edges of the renal arteries and 
compared, in order to assess whether the arteries originated 
from the abdominal aorta at the same anatomical and 
horizontal level. This data determines proximal siting of a 
stent and is useful for predicting the need for transrenal 
ostial fixation, especially in patients with a short aneurysm 
neck. Numbers and ostial patency (tested by direct probing 
and intubation) of the lumbar and median sacral arteries 
were individually determined. This is a frequent site of 
type-II endoleaks and perigraft collateral flow after EVAR.12 
Ostial size, patency and diameter of the inferior mesenteric 
arteries (IMA) were recorded. 
Infrarenal aortic measurements were performed and 
compared, as this data is necessary in the clinical context 
to determine sizing of the aortic prosthesis (body), thereby 
ensuring an accurate fixation at the aortic bifurcation. The 
presence or absence of large accessory renal arteries relevant 
to EVAR was recorded. This finding is often used as an 
exclusion criterion for EVAR, especially if the vessels 
are large and multiple. Posterior abdominal aortic plaque 
localisation was documented and graded as isolated or 
confluent (mild, moderate, severe). Ostial splinting of the 
distal aortic lumbar arteries by atheroma favours endoleak 
and collateral perigraft flow postprocedurally.12 For statisti-
cal analysis, parametric and non-parametric tests were 
utilised and data were stored in an Excel database. Data 
were considered statistically different if p < 0.05.
EVAR clinical study
In the clinical component of the study, 207 referred adult 
patients were prospectively assessed with AAA by a multi-
disciplinary interventionalist approach, according to the 
recommendations of the EVAR Consensus Meeting of 2003. 
Twenty-one per cent (44 of 207) were excluded from EVAR 
because of co-morbid disease and unfavourable aneurysm 
anatomy, angulation of the aneurysm neck, short neck, 
inadequate landing zones and access problems due to nar-
rowed, calcified and angulated iliac arteries.32 
One hundred and sixty-three patients, with a mean age 
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of 70.7 years, underwent EVAR over a six-year period. 
Median AAA diameter was 5.7 cm. American Society of 
Anaesthesiology (ASA) ratings were as follows: ASA II, 
15.9%; III, 57%; IV, 22.6%; V, 2.4%. Patients underwent 
EVAR using the inclusion criteria recommended by the con-
sensus 2003 Stellenbosch meeting of VASSA. All patients 
were offered open surgery as an alternative and entered into 
the VASSA EVAR Trial Registry. The procedure of EVAR, 
and the inclusion and exclusion criteria have previously 
been reported by Du Toit and Saaiman.12 Pre-operatively, 
patients were assessed by spiral CT and selectively evalu-
ated with conventional angiography.12 All patients signed 
informed consent and underwent EVAR by a multidiscipli-
nary interventional team, including vascular surgeons and 
a cardiologist12 During the five-year study period, different 
aortic stent devices were used. All patients underwent pre- 
and post-EVAR evaluation with duplex Doppler ultrasound 
assessment of AAA and were followed up at regular 
intervals indefinitely. Endoleaks were defined as follows:12
• type I: graft related (perigraft inflow with and without 
outflow)
• type II: retroleaks from either the lumbars or inferior 
mesenteric artery (inflow, with and without outflow)
• type III: prosthetic overlap leak
• type IV: porosity leak (? suture holes)
• type V: unknown origin.
Results: morphological component
Abdominal aorta, variations, relevant to EVAR
The mean age of 31 adult cadavers was 49 years (range 
27–90 years). Circumference of the aorta at the level of 
the superior edge of the renal artery orifice in 30 non-
aneurysmal cadavers measured a mean of 4.2 cm (range 
2.8–5.6 cm). Circumference at the level of the inferior edge 
of the renal ostia in the same cohort measured 4.0 cm (range 
2.9–5.6 cm) (superior versus inferior circumferences were 
not significant: p > 0.05). In 27 of 30 cadavers (90%), the 
renal arteries took origin from the aorta at different levels. 
In three cadavers, the renal arteries were duplicated (10%). 
In two of the three cadavers, triple renal arteries were 
present on the left aortic side. In three of these cadavers, 
an anomalous inferior origin of the SMA was detectable. 
SMA ostia in these three patients were sited between the 
renal arteries (Fig. 1). The mean difference in level of origin 
(measured at the inferior ostial edge) of the left and right 
renal arteries was 6.9 mm (range 1–17 mm). Sixty per cent 
(6 of 10) of ostial orifice levels differed by 1 cm or more. 
The mean distance between the aortic bifurcation and the 
inferior edge of the left renal artery was 8.8 cm (range 
6.6–11.4 cm). On the right side, the mean distance between 
the aortic bifurcation and the right renal artery was 9.6 
cm (range 6.2–12.9 cm). Statistically, this difference was 
not significant.
Infrarenal or accessory polar renal arteries occurred in 
four of 31 cadavers (13%). In one cadaver, a large left-sided 
accessory artery originated from the abdominal aorta adja-
cent to the IMA. In three of four specimens, accessory renal 
arteries were observed on the left side. In all specimens, 
the inferior mesenteric artery (IMA) was patent. Mean 
ostial diameter was 3.9 mm (range 1.6–5.9 mm). Regarding 
the ostial diameters, the following measurements were 
recorded: 4.4 mm (25%), 4.9 mm (14.3%), 5.9 mm (10.7%) 
and 1.6 mm (3.6%). The mean distance between the aortic 
bifurcation and the ostia of the IMA was 3.9 cm (range 
2.0–6.1 cm). One hundred and sixty-one lumbar arteries 
were detected in the cohort studied. In two of 161 (1.2%), 
the lumbar ostia were not patent. The mean number of 
lumbars per patient was 5.7 (range 3–9). Ten patients had 
eight or more lumbar arteries. In three patients, only single 
lumbars were present: the rest had paired lumbars. In 71% 
of the cohort studied, the median sacral artery (MSA) was 
identifiable, and in 60.7%, the ostium was patent. In 46% 
of cadavers, the MSA ostia were situated in the midline 
just superior to the aortic bifurcation. In 28% of cadavers, 
the MSA ostia were situated just to the left of the aortic 
bifurcation and adjacent to the ostia of the left common 
iliac artery.
Posterior abdominal aortic plaque occurred in nine of 31 
cadavers (29%) at a mean age of 57.7 years (range 40–74 
years). Large atherosclerotic and calcified plaques were 
present at the aortic bifurcation in 6.7% of cases. Plaque 
formation at the bifurcation and zone inferior to the IMA 
occurred in 10% of cadavers, some showing identifiable 
atherothrombosis.
Gonadal (testicular, ovarian) and ureteric arteries were 
constantly present as paired arteries, but differed in diameter. 
In one cadaver, the right inferior adrenal artery took origin 
from the infrarenal aorta, just inferior to the right renal artery.
In one cadaver, a right-sided lumbar ectopic kidney 
was present (Fig. 2). The right renal artery of this kidney 
took origin 1.5 cm superior to the aortic bifurcation. An 
inferior polar artery was visible and took origin from the 
contralateral, left common iliac artery. Horseshoe kidneys 
were not detected in this study. Patent MSA ostia are 
reflected in Fig. 3.
In one cadaver, a large 6-cm ruptured aortic aneurysm 
was present, which had led to exsanguination and death of 
Fig. 1. Anatomical specimen showing an inferior 
ectopic origin of the SMA sited between the renal 
arteries (duplicated on the left side). This anomaly 
would preclude transrenal fixation of a prosthesis 
during EVAR in a patient with AAA and a hostile 
neck.
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the patient. Fig. 4 shows an infrarenal, ruptured abdominal 
aortic aneurysm viewed from the ventral surface. A 20-mm, 
non-angulated aneurysm neck was present. Supra- and 
infrarenal aortic measurements were 19 and 16 mm, respec-
tively. The origins of the renal arteries were eccentric and 
no polar vessels were present. Aneurysm diameter was 60 
mm, with posterior erosion of three vertebral bodies and 
20-mm postero-lateral rupture. Bifurcation diameter was 
27 cm. A concomitant 3-by-3-cm right-sided common iliac 
artery aneurysm was present. Lumens of the external iliac 
artery ostia measured 11 mm on both sides. Both vessels 
were patent. Four patent lumbar arteries were detected. 
One had a large ostium and communicated with iliolumbar 
arterial collaterals. The length of the aneurysm sac measured 
100 mm. Free intraperitoneal rupture was present with a 
large clot in the left paracolic gutter and pelvic cavity. 
Aneurysm sac morphology would have permitted either open 
surgical repair or management by EVAR. Aneurysm neck 
and landing area morphology favoured endoluminal stenting.
EVAR clinical study
In a 60-month prospective clinical study, successful stent-
deployment rate was 99% and rendered a primary patency 
stent rate of 97%. At 30 days, the results were as follows: 
surgical conversion 0.6%; procedural or intra-operative 
mortality 1.2%; 30-day operative mortality 4.3%; and need 
for secondary interventions 24.5%. This included staged 
and planned interventions over 30 months after EVAR, such 
as cuffing or insertion of additional stents to address type-II 
endoleaks. Follow-up period was a median of 28.3 months 
(range 1–69 months). 
Co-morbidities that contributed to late mortality and 
attrition included ischaemic heart disease, cardiomyopathy, 
renal failure, stroke and cancer. Details of late mortality 
post-EVAR are provided in Table I. One procedural rupture 
was fatal (0.6%). Two late ruptures occurred, one was 
successfully endostented and the other patient died after a 
failed surgical intervention (0.6%). The 30-day outcome and 
endoleak type, according to endograft used, are reflected 
in Tables II, III and IV. Intraprocedurally, aneurysm sac 
pressure measurements together with angiography were 
utilised to detect type-I or -II endoleaks and obvious 
patent lumbar arteries. Selective intraprocedural cuffing, 
coil embolisation and thrombin injection were used to seal 
endoleaks originating from lumbar arteries. In two patients, 
coils were used and in another 11, thrombin was injected 
into angiographically detected endoleaks to afford sealage. 
Two patients with suspected but unproven type-I persisting 
endoleaks are being followed up. Surgical or endovascular 
interventions are under consideration. In three patients, 
endotension was diagnosed, but an endoleak from a lumbar 
artery could not be detected (1.8%).
Fig. 3. Anatomical specimen of the inferior aspect 
of the abdominal aorta. Note paired lumbar ostia 
surrounded by hard circumferential atherosclerotic 
plaque, a large median sacral artery (MSA), and 
small ectopic MSA sited in the orifice of the left 
common iliac artery. This is frequently the site and 
origin of lumbar endoleaks after EVAR.
Fig. 4. Anatomical specimen showing a ruptured 
6-cm abdominal aortic aneurysm. A concomitant 
right common iliac artery aneurysm is present. 
Aneurysm neck morphology and iliac artery meas-
urements favour either conventional surgery or 
EVAR.
Fig. 2. Anatomical specimen showing the abdomi-
nal cavity from anterior, and a right ectopic kidney. 
The origin of the right renal artery would exclude 
EVAR in a patient presenting with an AAA and this 
vascular anomaly. Ostial occlusion will result in 
extensive segmental renal infarction.
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Discussion
Comprehensive knowledge of aberrant morphological anat-
omy of the abdominal aorta, collateral aortic side branches, 
variations and growth evolution of AAA is of critical 
importance to the interventionalist striving to reduce the 
incidence of endoleaks and perigraft flow.1-3,27-31,33 Anomalies 
of the abdominal aorta impact on stent selection, sizing, 
placement, fixation and sealage. Anomalies affecting aortic 
side branches and take-off may well be predictors or risk 
factors for endoleak formation. Aortic and side branch 
variations, as described, influence inclusion and exclusion 
criteria for EVAR. An endoleak is defined by the persistence 
of blood flow outside the lumen of an endoluminal graft, 
but within the aneurysm sac.32 
Endoleaks are classified as type I, II, III and IV.32 It is 
accepted that an endoleak is evidence of incomplete exclu-
sion of an aneurysm from the circulation during or after 
EVAR.32 Various causes have been cited.14-17,19-26 Important 
causes include incomplete seal between the endograft 
and aortic wall, retrograde blood flow from patent aortic 
side branches, fabric defects or porosity, poor sealing 
between the components of a modular prosthesis, and device 
failure.19,24 
Pre-operatively, prediction of endoleak incidence is not 
accurate, despite using spiral CT.10,12 Type-I endoleaks (inef-
fective seal at either the proximal or distal graft ends 
or attachment zones), if not controlled, correlate strongly 
with delayed aneurysm rupture after EVAR.18,32 A type-II 
endoleak is associated with retrograde or perigraft flow 
from lumbar arteries, the inferior mesenteric artery (IMA), 
or other collateral vessels.15,16,19,20,22-25 
Pre-operative assessment of aortic side branches and vari-
ations is not consistently accurate. This applies especially 
to aberrant lumbar artery anatomy in the distal aorta. Origin 
and outflow patterns have previously been reported by Du 
Toit and Saaiman and include lumbar–lumbar, lumbar–IMA, 
accessory renal–lumbar/IMA, hypogastric–lumbar/IMA or 
undefined.32 Knowledge of applied anatomy of aortic side 
branches and anomalies are important to categorise aetiol-
ogy, diagnosis and treatment strategies of endoleaks.32 
This allows the interventionalist to prognosticate regarding 
potential obliteration of the retroleak with significant peri-
graft flow. 
Connection of flow to proximal or distal graft end, 
even in the presence of retrograde flow from a lumbar or 
IMA vessel, classifies an endoleak as type I.32,34 The risk 
of late aneurysm rupture in these patients is prohibitive. 
Endotension refers to the problem of continued enlarge-
ment of an AAA after EVAR, often in the absence of a 
detectable endoleak.15,21 Aneurysm sac enlargement under 
these circumstances may lead to aneurysm rupture.15,18,21 
TABLE I. LATE MORTALITY:* CO-MORBIDITIES AND 
MORTALITY PROFILE AFTER EVAR (n = 35)
Co-morbidity status   
before stenting n Cause of death after EVAR n
Cardiac (IHD) 24 (68%) Stroke1  3
Cardiomyopathy 5 Cancer (mean 14.3 months) 9
Respiratory 9 Multi-organ failure2  3
Diabetes mellitus 4 Myocardial infarction3   7 (20%)
Stroke  (ischaemic) 3 Pneumonia 2
EF < 43% 9 Cardiac failure 2
Arrythmia 4 Septicaemia (unknown) 2
Cancer  2 Renal failure4  2
Hypertension 16 (45%) Cardiomyopathy 3
PVD 10 Ruptured AAA 1 (0.6%)
Renal insufficiency 2 Bee sting anaphylaxis 1
Liver cirrhosis 1 Endograft sepsis5  1 (0.6%)
Obesity 1 Unknown cause 1
Hostile abdomen 1 Cardiac-related deaths 13 (35%) 
AAA rupture 1
Comorbidity combinations 28 (80%) 
Age > 90 years 1
*Majority of late deaths post-EVAR occurred between 18 and 60 months.
1Non-procedure related (occurred between 18 months and 60 months post-
EVAR).
2Two cases were associated with aneurysm rupture. Another occurred after 6 
months in a patient with cholangiocarcinoma, jaundice and cholangitis.
3One acute coronary syndrome occurred after stenting and was successfully 
salvaged by coronary intervention. Six occurred after 6 months in patients with 
three-vessel disease and considered high-risk patients.
4Non were procedure related. These occurred in two patients with multi-organ 
failure.
5Clinically suspected, but not bacteriologically proven.
TABLE II. EVAR OF AAA 30-DAY OUTCOME (n =163)
Variable Total Percentage
Successful deployment 162 99
Surgical conversion 1 0.6
Procedural mortality 2 1.2
30-day mortality 7 4.29
Secondary interventions 40 24.53
TABLE III. TOTAL ENDOLEAK RATE AND LOCATION 
AFTER EVAR – PROCEDURAL AND BEFORE
EXCLUSION
 AneuRx® Talent® Powerlink® Vanguard®
Total pts stented 47 49 62 3
No endoleak 30 35 47 1
Type I 15 13 11 2
Type II 1 1 3 0
Type III 0 0 0 0
Type IV 0 0 0 0
Indeterminate 1 0 1 0
Total endoleaks 17 1 15 2
TABLE IV. ENDOLEAK RATES AND LOCATIONS 
AFTER EVAR (AFTER EXCLUSION = PERSISTING)
 AneuRx® Talent® Powerlink® Vanguard®
Total pts stented 47 49 62 3
No endoleak 46 49 61 3
Type I    
Type II 1* 0 1** 0
Type III 0 0 0 0
Type IV 0 0 0 0
Indeterminate 0 0 0 0
Total endoleaks 1 0 1 0
*Endoleak excluded at three months, persists at 16 months.
** Patient not yet seen at follow-up.
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Endoleaks and endotension therefore remain an active area 
of investigation because of the danger of unexpected late 
rupture and aneurysm-related death after EVAR.15,19-26
Endoleaks almost never manifest after conventional open 
aneurysm repair because lumbar orifices are intentionally 
ligated to prevent back-bleeding into the sac.4,6-9 The IMA 
is ligated or reimplanted into the prosthetic endograft. 
Endoleak formation following endoluminal treatment of 
AAA is regarded as the Achilles heal of EVAR, if improperly 
managed, because late rupture of the stented aneurysm sac 
may occur.15,19,23,25 
We believe that it is possible to reduce the implications 
and negative sequelae of late or persisting endoleaks by 
adopting a proactive policy of intraprocedural aneurysm sac 
pressure monitoring, selective angiography and exclusion of 
perigraft flow by planned and intentional coil embolisation 
or thrombin injection into the sac. Detailed knowledge of 
lumbar artery anatomy and variations, including collateral 
circulation with the hypogastric arteries, is critical in post-
procedural decision-making. Precise anatomical localisation 
of retroleaks by angiography is imperative if coil embolisa-
tion is to be considered. Careful study thereof is required, 
as side-branch anatomy is distorted in patients with large 
aortic aneurysms and not always accurately visualised by 
conventional intraprocedural angiography.
An important vascular consensus meeting with a focus 
on the importance of post-EVAR endoleaks was held in 
2002 under the auspices of the Society of Vascular Surgery 
and the American Association for Vascular Surgery.15 One 
of the concerns that was pointed out is that the mid- 
and long-term durability of endografts used during EVAR 
and the effectiveness in prevention of rupture remains 
questionable.15 
One of the principal reasons for device failure one year 
after EVAR is the occurrence of significant and persisting 
endoleaks. In some patients, endoleaks and endotension are 
critically important problems after EVAR. Consensus at the 
international conference was that the current classification 
system of endoleaks, with some important modifications, 
is adequate.15 The recognised incidence of type-I and -II 
endoleaks after EVAR is 0–10% and 10–25% respectively.15 
Many type-II endoleaks will seal spontaneously and are not 
regarded as being associated with detrimental effects.15 An 
enlarging aneurysm after EVAR mandates early surgical or 
interventional treatment.15 Consensus and general agreement 
was reached regarding treatment strategy for the latter 
entity.
Pre-treatment of patent lumbar and inferior mesenteric 
arteries in some way before EVAR was considered contro-
versial.15 Precise localisation of all lumbars is needed if 
this approach is adopted. The prevailing opinion at the 
consensus meeting was that 2–15% of type-II endoleaks 
were associated with an unfavourable outcome.15 Some 
interventionalists have commented that the ‘bad outcome’ 
may be due to an unrecognised, simultaneous type-I leak.15 
Of interest was the finding that coil embolisation of type-I 
or type-II endoleaks may be ineffective.15 Laporoscopic 
clipping of aortic collateral branches has remained a pop-
ular approach by some workers to type-II endoleaks.15 
Knowledge of applied aortic anatomy is desired to achieve 
positive outcomes, thereby reducing the chances of late 
aneurysm rupture. 
From the published literature, it is clear that much 
remains to be learned about the causation of endoleaks and 
endotension, and how they may be optimally prevented 
and treated.15 For instance, it is now established that 
some endoleaks cannot be detected with optimal CT scan-
ning.32 Many units have shown that duplex ultrasonography, 
although useful, is not the best method for the detection 
of the anatomical origin of endoleaks.32 Ultrasonography, 
although non-invasive, is not always accurate for the detec-
tion and precise localisation of type-II endoleaks.32
In the current clinical study, the overall type-I procedural 
endoleak rate before exclusion was 25.1%. After intrapro-
cedural endoleak exclusion, the incidence was reduced to 
1.2%. Other units report an endoleak incidence rate varying 
from 15 to 25%.15,19-26 Regarding type-II endoleaks before 
exclusion, five were detected (3%) either by ultrasonogra-
phy or spiral CT. All were successfully excluded either 
by coil embolisation or thrombin infusion into the sac. 
Intraprocedural aneurysm sac pressure measurement, togeth-
er with angiography, facilitated planned intraprocedural 
exclusion thereof. Using this strategy, only two persisting 
(1.2%) endoleaks were detectable during follow-up duplex 
Doppler examinations. 
The problem of post-EVAR endotension is well docu-
mented in the literature and the treatment thereof remains 
controversial.15 In the present study, three patients (1.8%) 
have endotension and are undergoing careful follow-up 
surveillance. In the current study, no perigraft flow could 
be attributed to a back-bleed from the IMA. However, 
two patients (1.2%) developed colonic ischaemia within 30 
days of EVAR. Renal atheroembolisation or renal infarction 
was not detectable procedurally or beyond 30 days. Other 
workers have reported on the incidence of renal infarction 
after EVAR.35
Results of the morphological studies in dissected labora-
tory specimens without AAA revealed important applied ana-
tomical anomalies and aberrations relevant to a successful 
EVAR outcome and potential development of endoleaks.22 
These anomalies are poorly delineated in standard and 
classic works of anatomy. The origin of the renal arteries, 
and therefore the ostia, were dyssynchronous in 90% of 
the cases we examined. In almost all cadavers studied, the 
left renal ostium was inferior to the origin of the right 
renal artery. With regard to EVAR, this relation is critical 
in accurate placement of the proximal edge of the stent, 
especially in patients with a hostile and angulated neck. This 
information is also useful if supra- or transrenal fixation 
is contemplated.35 Care must be exercised not to occlude 
inferiorly sited main renal ostia with the stent, or when 
using extra cuffs to seal intraprocedural type-I endoleaks. In 
10% of the cadavers, the SMA took origin between the 
renal arteries. This anomalous anatomical finding rules out 
the safe application of trans- or suprarenal fixation of a 
stent, as SMA occlusion could occur, resulting in total small 
intestinal ischaemia.35 
Accessory polar renal arteries were present in 3.3% of 
cases and this anatomical finding is a predictor of segmental 
renal infarction if EVAR is considered in such patients. 
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Also stent closure of the ostia of these vessels may result 
in segmental renal ischaemia and renal failure.34 In 6% 
of cadavers, an inferior ectopic origin of a large right 
renal artery and accessory renal artery was present. This 
vessel anomaly altogether excludes safe application of 
conventional EVAR and will result in infarction of a whole 
kidney or a large segmental infarct. Many units consider 
such vascular anomalies as exclusion criteria for EVAR. 
Regarding the size of the IMA ostia, 10.7% were greater 
than 5.9 mm in diameter. This finding may well explain 
the reason for endoleak formation reported in the literature 
and colonic ischaemia after EVAR. During conventional 
surgery, these large vessels are traditionally and selectively 
re-anastomosed to the prosthetic endograft for the purpose 
of reducing colonic ischaemia. The mean number of lumbar 
arteries per cadaver was 5.7 (range 3–9). These numerical 
data are not always appreciated during insertion of an aortic 
endoluminal stent. Often, on-table completion angiography 
does not adequately highlight all these vessels. In 33% of 
cadavers, eight or more lumbars were present, obviously 
increasing the chances of type-II endoleaks in the clinical 
situation, especially if these ostia were patent and large. 
More than 90% had patent ostia. Twenty per cent of cada-
vers had large patent lumbar ostia. This finding, theoreti-
cally, would favour type-II endoleak formation.33 Our multi-
disciplinary group has identified this observation as an 
important finding, especially with regard to large distal 
aortic lumbar arteries and retroleaks. 
Patency of the median sacral artery (MSA) was demon-
strated in 70% of the cadaveric cohort study. Of interest 
was the finding, in a small cohort, of the orifice of MSA 
at the origin of the left common iliac artery. This finding 
is technically relevant as uncontrolled patency of the MSA 
is also known to be associated with perigraft flow and 
endoleak. Our study could not confirm or exclude this 
possibility. Anatomically, smaller aortic side branches are 
occluded during EVAR: gonadal arteries (95%), inferior 
ureteric arteries (95%) and inferior adrenal artery (3%). The 
clinical significance may be unpredictable or unimportant. 
Anatomically, when considering EVAR for patients with 
AAA, ectopic kidneys (3%), multiple main renal arteries 
(10%), accessory renal arteries (13%) and horseshoe kidneys 
pose substantial challenges for the inexperienced interven-
tionalist working in low-volume units. This also applies 
to vascular surgeons considering conventional surgery for 
AAA. Mean measurement between the aortic bifurcation 
and left renal artery in 30 cadavers was 8.8 cm (range 
6.6–11.4 cm). These differences and discrepancies in infra-
renal aortic length may impact negatively on the selection 
of the optimal length and type of stent body for EVAR. 
This applies especially to the use of first-generation aortic 
stent devices. 
Theoretically, an anatomical misfit of the body of the 
stent adjacent to the bifurcation may predispose to poor 
sealing of inferior lumbars and MSA. Stent–host wall 
mismatch due to distorted anatomical morphology and 
varying distances in aortic length may contribute to the 
development of type-II endoleaks and eventual distal migra-
tion of the stent body. The latter problem may be the 
explanation for the development of late type-I endoleaks 
and eventual post-EVAR aneurysm rupture. This is a topical 
point, as the effect of remodelling of the aneurysm on 
aortic endografts after EVAR is not fully understood and 
appreciated. We believe this to be an important issue, as 
30% of our cadavers (mean age 57.7 years) had severe, 
posterior abdominal atherosclerotic aortic plaque, theoreti-
cally, influencing long-term aneurysm remodelling and 
contribution to late endoleak formation after EVAR.
In conclusion, type-II endoleaks originating from patent 
infrarenal aortic side branches are an important drawback of 
EVAR. Diagnostic and management strategies remain con-
troversial. Pre-operative imaging of aortic side branches can-
not always predict the incidence of post-EVAR endoleaks. 
Comprehensive anatomical knowledge of the aorta and its 
side branches is a prerequisite, if satisfactory endoleak-free 
results are to be attained after EVAR, thereby reducing 
the need for secondary interventions. The incidence of post-
EVAR type-II endoleaks can be reduced by intra-operative 
utilisation of aneurysm sac pressure monitoring, considering 
important anatomical variations of patent lumbar arteries, 
coil embolisation and selective injection of thrombin into 
the sac.
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